Skip to main content
NewslettersWatchlist

Boston Scientific Corp(BSX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Boston Scientific Corp

300 BOSTON SCIENTIFIC WAY
MARLBOROUGH MA 01752 USA
P: 508-683-4000
F: 508-650-8923
http://www.bostonscientific.com

Profile

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

Key Executives

NameTitle
Daniel J. BrennanCFO/Executive VP
Joseph M. FitzgeraldExecutive VP/President, Divisional
Michael F. MahoneyCEO/Chairman of the Board/Director/President
Vance R. BrownGeneral Counsel/Secretary/Senior VP
Wendy CarruthersExecutive VP, Divisional
Jeffrey B. MirvissExecutive VP/President, Divisional
John Bradley SorensonExecutive VP, Divisional
Eric Francis Yves ThepautExecutive VP/President, Geographical
Arthur C. ButcherExecutive VP/President, Geographical

More from The Globe

Activist investor targets Dye & Durham’s ‘underperformance and strategic missteps’ in letter to shareholders
Dye & Durham Ltd. says it has launched a strategic review of its non-core assets in an effort to reduce its debt. The logo for Dye & Durham Ltd. is shown in this undated handout photo. THE CANADIAN PRESS/HO
At midday: North American markets drop as Meta Platforms, U.S. economic data weigh
Traders work on the floor of the New York Stock Exchange shortly after the opening bell, Wednesday, April 24.
Fiera Capital’s largest shareholder looks to sell stake in company
Jean-Guy Desjardins, global CEO and founder of Fire Capital posses for a portrait at Fiera Capital, in Montreal on Monday, January 8, 2024. Evan Buhler/The Globe and Mail�
The close: S&P 500 higher as markets weigh rising bond yields and upbeat U.S. earnings; TSX lower as rails slide
The Art Deco facade of the original Toronto Stock Exchange building is seen on Bay Street in Toronto in January of 2019.
The close: Stocks higher as investors digest earnings
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., March 20, 2024.
The close: Stocks higher with major corporate earnings on tap
A trader works on the trading floor at the New York Stock Exchange (NYSE) in New York City, U.S., April 5.
If pension funds can’t see the case for investing in Canada, why should you?
Ian McGugan
the rob interview
Head in the cloud: How Cisco CEO Chuck Robbins is reviving a Silicon Valley icon
Cisco CEO Chuck Robbins, seen in Toronto on Oct. 12, is a 6-foot-4 former college basketball player and 20-year veteran of the company. He steps into what no one would describe as a dream job: a lengthy slog to direct a one-time Silicon Valley star through its challenging next chapter.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.